RxDoctor Payments Data

Ronda Oconnell

Adult Health · Beaufort, SCNPI 1902152911

Payments from drug & device makers

$962in general payments, 2019–2025

Across 50 payments — averaging $19.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$164
  • AstraZeneca$138
  • Boston Scientific$101
  • Novo Nordisk$94
  • Exact Sciences$65
  • Astellas Pharma US Inc$55
  • plus $344 from 12 others

What the payments were for

  • Food & beverage$962100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$962 in reported general payments places this provider in the 50th percentile of 292 adult health providers in South Carolina.

See all adult health providers in South Carolina

Medicare billing

Part B allowed, 2024
$85,319
Medicare patients
291
Services billed
1,231

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$73,940
JardianceEmpagliflozin87$71,925
EliquisApixaban37$39,985
TrulicityDulaglutide19$18,681
MyrbetriqMirabegron22$16,263
Tresiba Flextouch U-100Insulin Degludec12$8,937
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$8,745
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$8,651
SymbicortBudesonide/Formoterol Fumarate11$6,622
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$4,571
Atorvastatin Calcium421$3,738
Gabapentin93$2,681
Omeprazole143$2,435
Levothyroxine Sodium261$2,114
Rosuvastatin Calcium110$1,906

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$94$73,94066 claims
Boehringer IngelheimJardiance$18$71,92587 claims
PfizerEliquis$29$39,98537 claims
Lilly USA, LLCTrulicity$164$18,68119 claims
Astellas Pharma US IncMyrbetriq$55$16,26322 claims
GSKTrelegy Ellipta$48$8,74512 claims
AstraZenecaSymbicort$138$6,62211 claims
AbbVieSynthroid$35$71415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 292 adult health providers in South Carolina.

Other adult health in Beaufort

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →